High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis
The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Do women with polycystic ovary syndrome (PCOS) have an increased prevalence of moderate and severe depressive and anxiety symptoms compared with control women, and do these symptoms correlate with age, BMI, testosterone, hirsutism or insulin resistance (IR)? SUMMARY ANSWER: Women with PCOS have significantly increased odds of moderate and severe depressive and anxiety symptoms, independent of obesity, and the symptoms are weakly associated with age, BMI, elevated testosterone, hirsutism and IR. WHAT IS KNOWN ALREADY: Previous studies have reported that women with PCOS have an increased prevalence of mild depressive and anxiety symptoms or an increase in mean depression and anxiety scores, although these scores are usually within the normal range. Thus, it is therefore not clear whether these findings are clinically significant. The prevalence of moderate and severe depressive and anxiety symptoms, which require follow-up and would benefit from treatment, is not known in this population. STUDY DESIGN, SIZE, DURATION: A comprehensive systematic review (SR) was performed up to January 2016 and included 30 cross-sectional studies, representing 3050 subjects with PCOS and 3858 controls, from 10 different countries. The meta-analysis (MA) on depressive symptoms included 18 studies and the MA on anxiety symptoms included 9 studies. A separate SR identified 15 studies for the meta-regression examining the associations with PCOS-related symptoms or comorbidities. PARTICIPANTS/MATERIALS, SETTING, METHODS: All studies included adult women with PCOS, defined by the National Institutes of Health or Rotterdam criteria, and a control group without PCOS. Ovid, Embase, PsychInfo and Cochrane were searched up to January 2016. Included studies used a validated screening tool to compare the prevalence or mean scores of depressive and/or anxiety symptoms. Random effects MA was used to estimate the pooled odds ratio (OR) of depressive and anxiety symptoms. Sensitivity analyses of methodological characteristics and a meta-regression of the pooled standardized mean difference (SMD) to evaluate PCOS-related clinical and laboratory associations were performed. MAIN RESULTS AND THE ROLE OF CHANCE: Women with PCOS had increased odds of any depressive symptoms (OR: 3.78; 95% CI: 3.03-4.72; 18 studies) and of moderate/severe depressive symptoms (OR: 4.18; 95% CI: 2.68-6.52; 11 studies). Women with PCOS had increased odds of any anxiety symptoms (OR: 5.62; 95% CI: 3.22-9.80, nine studies) and of moderate/severe anxiety symptoms (OR: 6.55; 95% CI: 2.87, 14.93; five studies). When subjects were matched on BMI, women with PCOS still had higher odds of both depressive (OR: 3.25; 95% CI 1.73-6.09; four studies) and anxiety symptoms (OR: 6.30, 95% CI: 1.88-21.09; three studies). There was no substantial heterogeneity among studies in the overall MA on depressive symptoms (I2 = 22.4%, P = 0.19), but there was significant heterogeneity among studies in the analysis on anxiety symptoms (I2 = 59.6%, P= 0.01). In the meta-regression evaluating pooled SMDs between groups, women with PCOS and concurrent depression had higher mean values of age, BMI, hirsutism score and IR, while women with PCOS and concurrent anxiety had higher mean values of BMI, hirsutism score and free testosterone (P < 0.05 for all comparisons). LIMITATIONS, REASON FOR CAUTION: All studies were cross-sectional, thus we can only hypothesize that the diagnosis of PCOS precedes the diagnosis of depression and anxiety. There were large variations in methodological characteristics especially in the studies screening for anxiety; however, they only partly explained effect size variation. WIDER IMPLICATIONS OF THE FINDINGS: This evidence-synthesis analysis shows that PCOS diagnosis is associated with an increased risk of moderate and severe depressive and anxiety symptoms and suggests that providers should consider screening women with PCOS for both depression and anxiety. Although age, obesity, hyperandrogenism and IR do not explain the entire association, well-designed studies are needed to assess the impact of treatment of these factors on depressive and anxiety symptoms in women with PCOS. STUDY FUNDING/COMPETING INTEREST(S): No funding was used for this study. There are no conflicts of interest. REGISTRATION NUMBER: N/A.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is concerning given the established evidence of increased depression, anxiety, eating disorders and other mental illnesses in those affected with PCOS [3, 8, 57–59].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [58]
In the citing paper
“This prevalence of eating disorders is relatively high compared to that found in other population studies that report a 0.3%-2.45% prevalence in those with PCOS.31,126,129,130”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [129]
In the citing paper
“Another meta-analysis estimated a prevalence of 36 % for depression in PCOS [69].”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [69]
In the citing paper
“The risk of developing depression may be associated with higher BMI [70], although this association is weak.”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [70]
In the citing paper
“A recent meta-analysis of depression rates among women with PCOS resulted in a median prevalence of depression of almost 37% compared to 14% in controls [8].”
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement
Siu, A. L., and the US Preventive Services Task Force (USPSTF), Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., García, F. A. R., Gillman, M., Herzstein, J., et al. (2016) · JAMA · doi:10.1001/jama.2015.18392 · Cited by 1,407
Research works printed but not linked: 3
- 2014, Body image, self-esteem and depressive symptomatology in women with polycystic ovary syndrome, Noropsikiyatri Arsivi, 51, 129
- 2013, Psychiatric symptoms in women with polycystic ovary syndrome, Dusunen Adam, 26, 157
- 1992, Polycystic ovary syndrome, 377
Cited by
Items 501–600 of 750
Yegane, D. F., Bahramikia, S., Babaeenezhad, E., & Dezfoulian, O. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02316-0 · Cited by 1
Tanvir, K. M., Faiza, M., Hossain, S. S., Shahriyar, S. M., Islam, T., Chowdhury, M. S., Sabbir, A., Turin, H. M., Islam, M. M., Mahiuddin, M., et al. (2026) · IEEE Access · doi:10.1109/access.2026.3710788 · Cited by 1
Pirga, G., Chwajta, G., Kaczor, G., Cichocka, W., Cepielik, B., Antos, M., Chmielnicki, F., Paczosa, K., Ostolski, M., & Jędruszko, K. (2026) · Quality in Sport · doi:10.12775/qs.2026.62.73200 · Cited by 1
Altaf, K., Rizwan, M., & Siddiqui, R. S. (2025) · Journal of Applied Research and Multidisciplinary Studies · doi:10.32350/jarms.61.05 · Cited by 1
Polycystic Ovary Syndrome (PCOS) and psychological burden: A Case-Control Study
Kriti, V., Kumari, S., & Joshi, S. (2026) · Indian Journal of Preventive & Social Medicine · Cited by 1
Adolescence: A High-Risk Period for PCOS Development?
Sultan, C., Gaspari, L., Hamamah, S., & Paris, F. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_2 · Cited by 1
Isnard, V., Paillet, S., Patin, V., Lesourd-Pontonnier, F., Pasquier, M., & Dewailly, D. (2018) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2018.11.009 · Cited by 1
Depression in Polycystic Ovary Syndrome
Barry, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30290-0_2 · Cited by 1
Non-surgical options to treat androgenic alopecia
Abdalla, M. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94168 · Cited by 1
The Trend of Four Consultation Models in Four Specialties at Four Tertiary Care Hospitals
Abdulghani, H. M., Sattar, K., Karim, S. I., Ahmad, T., Akram, A., Alsalem, R., Alruwaite, M., Alkhraiji, N., Al-Ghamdi, G. M., & Alkhulaifi, A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94153 · Cited by 1
Factors Associated with Not Continuing Initiated Breastfeeding among Saudi Females in Abha
Mandoura, Y. T., Alsaleh, M., & Alsaleem, S. A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94164 · Cited by 1
Impact of Covid-19 on asthmatic patients in Western region in Saudi Arabia
AlGhamdi, A. N. Z., Albaqami, A. M., Abdullah, A. M., Alsukhayri, D. A., Alawi, H. A., & Baabbad, A. S. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94161 · Cited by 1
Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
Бурка, О. А., Бобрик, М. И., Reznichenko, V. M., & Tutchenko, T. М. (2019) · Reproductive Endocrinology · doi:10.18370/2309-4117.2019.47.35-42 · Cited by 1
Exercise interventions in women with Polycystic Ovary Syndrome
Moreno‐Asso, A., Patten, R. K., & McIlvenna, L. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89843-0.00020-9 · Cited by 1
López, I. T., Ortiz, M. C. R., Castro, K. B. N., & Lara, D. G. (2022) · Revista Internacional de Acupuntura · doi:10.1016/j.acu.2022.100205 · Cited by 1
Yang, K., Chen, Y., Xiao-qing, Z., Zhen, Q., Gui, W., Ban, Y., He, Y., Pan, S., & Ding, M. (2022) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2022.2124267 · Cited by 1
Importance of lifestyle modifications
Das, B., & Fatima, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00030-x · Cited by 1
Zhang, X., Song, J., Liu, B., Dai, M., Wang, B., Cai, X., Hu, Y., Mao, Y., & Qu, F. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5009193 · Cited by 1
Hormonelle Regulation des menstruellen Zyklus und ihre Störungen
Ludwig, M. Z., & Weiss, J. M. (2024) · Springer eBooks · doi:10.1007/978-3-662-65517-7_3 · Cited by 1
The impact of type 2 diabetes on polycystic ovary syndrome in patients undergoing sleeve gastrectomy
Zhu, T., Zhao, Y., Bi, X., Zhao, P., Liu, T., Li, Y., Li, S., Zhao, S., Liu, S., & Huang, X. (2024) · Human Reproduction · doi:10.1093/humrep/deae159 · Cited by 1
Sehgal, S., Khan, A., & Behal, N. (2025) · International Journal of Medical Science and Clinical Research Studies · doi:10.47191/ijmscrs/v5-i02-07 · Cited by 1
Scott, H. C., Philpott, M., Berridge, G., Yu, Z., O'Brien, D. P., Becker, C., Lindgren, C. M., Oppermann, U. C. T., Müller, J., Fritsch, M., et al. (2025) · Journal of Endocrinology and Metabolism · doi:10.14740/jem1042 · Cited by 1
Husni, M., Rizk, D. E. E., Alabdulla, N. S., Zayed, A. M., Malas, H., Modahka, N. A., Alqujan, S. J., Alansari, B. K., Alhajri, S. E., Mahmood, N. S., et al. (2025) · Archives of Women s Mental Health · doi:10.1007/s00737-025-01589-8 · Cited by 1
Franks, S. (2018) · Clinical Endocrinology · doi:10.1111/cen.13900 · Cited by 1
Pan, J., Xiang, S., Dong, S., Qin, X., & Zhang, J. (2021) · Research Square · doi:10.21203/rs.3.rs-231675/v1 · Cited by 1
McIlvenna, L. C. (2021) · Victoria University Research Repository (Victoria University) · Cited by 1
Immune system response to the Covid 19 virus and 3rd boosters
Spigelman, M. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94159 · Cited by 1
Exacerbated health related quality of life amid morbidly Obese PCOS women from Faisalabad, PakistanPreprint
Ahmad, L., & Ulhaq, E. (2022) · Research Square · doi:10.21203/rs.3.rs-1316367/v1 · Cited by 1
Factors influencing self-consciousness in polycystic ovary syndrome (PCOS): A cross-sectional study.Preprint
Abdalla, M. A., Deshmukh, H., & Sathyapalan, T. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3930759 · Cited by 1
Kanwal, S., Fatima, S. S., Abid, F., Rafique, S., & Saba, N. (2024) · doi:10.22541/au.170666955.53539485/v1 · Cited by 1
van der Wel, A. W. T., Frank, C. M. C., Bout-Rebel, R., Duijnhoven, R. G., van Bree, B. E., Valkenburg, O., Al‐Nasiry, S., van Oppenraaij, R. H. F., Vogelvang, T. E., Westerhuis, M. E. M. H., et al. (2025) · medRxiv · doi:10.1101/2025.04.01.25325030 · Cited by 1
Delanerolle, G., Pathiraja, V., Mudalige, T., Wijamuni, N., Rathnayake, N., Haddadi, M. R., Phiri, P., Eleje, G. U., & Elneil, S. (2025) · Preprints.org · doi:10.20944/preprints202509.0728.v1 · Cited by 1
Frétel, M. (2023) · HAL · Cited by 1
Endocrine Care During Adolescence into Young Adulthood
Gleeson, H. K. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch19
Impact of Testosterone on Aspects of Psychology
Barry, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30290-0_4
Anxiety and Other Psychological Issues in PCOS
Barry, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30290-0_3
The Effect of Acupuncture on Decreasing Infertility Associated with Polycystic Ovary Syndrome
de Freitas, A. C. R. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/n4r6-5n30
(2020) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2020/9.4.5009
Distúrbios alimentares e consequências ginecológicas
de Faria, I. M. A. (2020) · Estudo Geral (Universidade de Coimbra)
Gestationsdiabetes/Diabetes und Schwangerschaft/Kommunikation mit Migrantinnen
Barakat, A., & Jäger, H. (2020) · Der Diabetologe · doi:10.1007/s11428-020-00683-y
The Relationship between Polycystic Ovary Syndrome and Psychological Symptoms
Pınar, G. (2021) · Journal of Clinical Research and Reports · doi:10.31579/2642-9756/040
The effect and regulation mechanism of CircHIAT1 on polycystic ovary syndrome
Wang, T. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Gestationsdiabetes und polyzystisches Ovarialsyndrom
Kollmann, M. (2021) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-021-00143-y
Exposición a bisfenol A y síndrome de ovario poliquístico: un problema emergente
Pérez-Díaz, C., García, M. M., & González‐Acedo, A. (2021) · Institutional Repository of the University of Granada (University of Granada)
Basic principles of diagnosis and treatment of diseases as part of hyperandrogenic syndrome
Kuznetsova, I. V. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-26-8-13
Quality of Life and Sexual Health
Tiranini, L., Stincardini, G., Righi, A., Cucinella, L., Piccinino, M., Rossini, R., & Nappi, R. E. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_8
Knowledge, Attitude and Awareness towards Corneal Donation in Aseer Region, Saudi Arabia
Alamri, A., Alqahtani, F. M., Alqahtani, H. A., Alqahtani, M., Alqahtani, M. M., Shibli, M. A. A., & Almastour, R. A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94162
Clinical Efficacy and Cholesterol-Lowering Effects of Inclisiran
bin Daud, M. D. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94166
Impact of COVID-19 on patients receiving chemotherapy for gynecological cancer
Andijani, M. N., Alibrahim, A. O., Tmraz, S. F., ALshenqity, L. F., Alaama, A. S., Zaatari, B. A., Anfinan, N. M., & Sait, K. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94158
AlShareef, F., Al-Faris, A., Alhafez, N. A., Albulosh, A. S., Aljuhni, A., Almahmoud, K. A., Almajdui, M. A., Alswayed, K. E., Alghuraybi, S. I., Alomary, S. A., et al. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94157
El-Gamal, F., Aljudaibi, A., Alzahrani, A., Alharthy, L., & Huwait, T. A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94155
‘SCIENCE’ (Design4Science exhibition)
Ling, M. (2008) · Sunderland Repository (University of Sunderland)
Abdalla, M. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94167
Härtl, K., Kästner, R., & Kowalcek, I. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23917-5.00010-0
dos Reis, F. M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734661183.793559339
Faculty Opinions recommendation of Polycystic ovary syndrome throughout a woman's life.
dos Reis, F. M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731435450.793559354
POLICISTINIŲ KIAUŠIDŽIŲ SINDROMO IR DEPRESIJOS SĄSAJA
Miliauskaitė, A. (2022) · Health Sciences · doi:10.35988/sm-hs.2022.160
FORENSIC PERSPECTIVES OF PCOS AND ADOLESCENT SUICIDE: A CASE REPORT
Naveen, A., Sahu, M. R., Padhi, K. S., & Mohanty, M. K. (2022) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/8601441
Peigné, M., Barbotin, A., Silva, M. S. B., & Giacobini, P. (2022) · Médecine thérapeutique / Médecine de la reproduction, gynécologie et endocrinologie · doi:10.1684/mte.2022.0895
PSICHIATRINIŲ SUTRIKIMŲ PASIREIŠKIMAS MOTERIMS, SERGANČIOMS POLICISTINIŲ KIAUŠIDŽIŲ SINDROMU
Piesliakaitė, K. (2023) · Health Sciences · doi:10.35988/sm-hs.2023.003
A MODERN VIEW OF THE POLYCYSTIC OVARIAN SYNDROME
BRAGA, M., Bordea, E. A., Brătilă, E., Marinescu, B., & Carp-Velişcu, A. (2020) · Annals of the Academy of Romanian Scientists Series of Medicine · doi:10.56082/annalsarscimed.2020.1.5
He, H., Zhang, S., Wang, Y., & Wu, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2575761/v1
PCOS with Metabolic Syndrome and Psychological Distress
Zinnataranasreen, S., & Huq, S. (2020) · Archives of Reproductive Medicine and Sexual Health · doi:10.22259/2639-1791.0301005
wang, L., Liu, Y., Guo, Y., Yan, X., Ding, R., & Huang, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2618490/v1
Rocha, T. P. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-26042023-163620
Behandlungen zur Verbesserung der psychischen Gesundheit beim PCOS
Barry, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-24461-2_8
Depressionen beim polyzystischen Ovarialsyndrom
Barry, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-24461-2_2
Auswirkungen von Testosteron auf Aspekte der Psychologie
Barry, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-24461-2_4
Ängste und andere psychologische Probleme beim PCOS
Barry, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-24461-2_3
26. A Lifespan Approach to Black Women’s Mental Health and Sexuality: Kellye’s Story
Holden, K. B., Rachel, S. A., Reid, R., Belton, A. S., & Omole, F. S. (2023) · American Public Health Association eBooks · doi:10.2105/9780875533414ch26
Pruneti, C. A., Guidotti, S., & Cosentino, C. C. (2023) · Clinical Journal of Obstetrics and Gynecology · doi:10.29328/journal.cjog.1001142
Polycystic Ovary Syndrome in Pediatric Obesity
Pereira-Eshraghi, C., Al-Rayess, H., Bomberg, E. M., & Cree‐Green, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-37380-0_11
Development of mental disorders in patients with polycystic ovary syndrome
Aguiar, A. J., Eloa, O. F. P., Maria, G. B. S., & Benvindo, F. S. (2024) · Journal of Gynecological Research and Obstetrics · doi:10.17352/jgro.000123
Shulaeha, U., Tahir, A. M., Abdullah, N., & Sunarno, I. (2023) · Bali Medical Journal · doi:10.15562/bmj.v12i3.4740
Energy Dynamics in the Metabolic Syndrome: Underpinnings of an Evolving Global Catastrophe
Thorp, K. E., Thorp, E. M., & BS, F. W. (2024) · The Gazette of Medical Sciences · doi:10.46766/thegms.endocrinol.24051901
MENTAL HEALTH IMPLICATION OF POLYCYSTIC OVARY SYNDROME (PCOS); A CROSS-SECTIONAL STUDY
Fatima, Jamal, I., Khan, M. M., Gul, E., Gul, H., & Zaman, S. (2021) · doi:10.53555/jptcp.v28i2.6796
PLASMA PROLIDASE ACTIVITY AND ITS RELATION WITH NUMBER OF CYSTS IN POLYCYSTIC OVARY SYNDROME
Fatima, M., Amjad, S., Illahi, M. I., Ahmed, T., Ansari, H., & Rehman, R. (2024) · Pakistan Journal of Physiology · doi:10.69656/pjp.v20i2.1617
Journal of Women’s Health Clinical Update
Kling, J. M., Kapoor, E., & Faubion, S. S. (2024) · Journal of Women s Health · doi:10.1089/jwh.2024.0882
Velisetti, K. S., Vankadavath, M. N., Pilladi, S., SVBSRN, I., & Molleti, V. K. (2024) · Journal of Pharma Insights and Research. · doi:10.69613/k027h464
Stolen Femininity of Women with Polycystic Ovarian Syndrome: A Review
Sumri, H. H. A., Kindi, R. A., Sumri, S. A., Hadhrami, R. A., & Salmani, A. A. A. (2025) · Oman Medical Journal · doi:10.5001/omj.2025.59
Self-Regulation In Polycystic Ovarian Syndrome
Kamali., D., Srivarshini., M., Tharuna., M., & Cardiliya., A. P. (2025) · Cuestiones de Fisioterapia · doi:10.48047/qevpy624
Kaymaz, N., Uzun, M. E., Şirin, H., & Kara, Ö. (2025) · Trends in Pediatrics · doi:10.59213/tp.2025.155
Prevalence of Body Dysmorphia in Polycystic Ovary Syndrome ( PCOS) Patients
Al-Ali, F. S., Al-Shujaie, M., & Flood, J. (2025) · Medical Archives · doi:10.5455/medarh.2025.79.27-33
Patel, N., Shaker, I. A., Patel, K., & Mangrola, N. Y. (2025) · National Journal of Community Medicine · doi:10.55489/njcm.160520255258
Shukla, A., Verma, S., Ramakant, R., Mishra, A., & Farzana, K. (2025) · International Journal of Forest Animal and Fisheries Research · doi:10.22161/ijfaf.9.2.2
Kumar, A., & Udayan, U. K. (2024) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v5i11.1835
Ghose, S., & Krishna, S. R. (2025) · Indian Journal of Medical Specialities · doi:10.4103/injms.injms_191_24
Silva, V., Soares, S. R., & Miguelote, R. F. O. (2025) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2025.100307
Addressing a Key Metabolic Component of PCOS: Insulin
Hopkins, D., & Chappell, A. (2025) · Obstetrics and gynecology. · doi:10.5772/intechopen.1010981
Polycystic Ovary Syndrome – A Clinical and Psychosocial Perspective
Strzałkowska, P., Mazur, A., Dulęba, J., Sajewicz, K., Tudaj, O., Kaźmierczak, M., Kalas, W., Kalisiak, J., Koszałko, J., & Kin, F. (2025) · Quality in Sport · doi:10.12775/qs.2025.43.61284
Comorbidity patterns and predictive factors in polycystic ovary syndrome: a cross-sectional study
Rawat, G., Gupta, H., & Kumari, N. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20252328
Altaf, K., & Rizwan, M. (2025) · ACADEMIA International Journal for Social Sciences · doi:10.63056/acad.004.03.0517
Gewichtsveränderungen bei PCOS – medikamentös beeinflussbar?
Arjune, S., Kretschmer, A. C., & Hanßen, R. (2025) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-025-00404-y
Stress, Coping Styles and Symptom Severity in Women with PCOS
Azeezuddin, A., & Nikitha, S. (2025) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2025.v07i04.53584
Kumaravelu, R., Dhevi, B., & Thulasi, A. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20252719
POLYCYSTIC OVARY SYNDROME (PCOS): THE OVERLOOKED PSYCHIATRIC STRUGGLE
Wubuli, D., Gupta, I., & -, B. A. M. D. (2025) · International Journal of Recent Advances in Multidisciplinary Research · doi:10.64485/ijramr.30.08.20256040
Ginecologia e Obstetrícia Ed. XX
LEIVAS, L., CARVALHO, G. D., WESCHENFELDER, C. A., MARTINS, A. S., FREITAS, G. B. L. D., & NASSIF, M. P. (2025) · Editora Pasteur eBooks · doi:10.59290/978-65-6029-277-2
Síndrome Do Ovário Policístico
Pinheiro, E. G. H., Piao, E. V., Zapaterra, I. L., & Prado, I. P. (2025) · Editora Pasteur eBooks · doi:10.59290/4892250252
Metadata
- Authors
- Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A.
- Affiliations
- Hospital of the University of Pennsylvania (US)
- Corresponding author
- Cooney, Laura G.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-09
- Volume
- 32
- Issue
- 5
- Pages
- 1075-1091
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2592269563
- Cited by
- 631
- References
- 80
- Citations by year
- 2026: 95 · 2025: 94 · 2024: 63 · 2023: 81 · 2022: 70 · 2021: 77 · 2020: 56 · 2019: 49 · 2018: 35 · 2017: 10
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- polycystic ovary syndrome, depressive symptoms, anxiety symptoms, depression prevalence, anxiety prevalence, obesity, insulin resistance, testosterone, hirsutism, body mass index, age, women's mental health, comorbidities, Rotterdam criteria, NIH criteria, screening tool, meta-regression, standardized mean difference
- MeSH terms
- Anxiety, Depression, Female, Humans, Polycystic Ovary Syndrome, Severity of Illness Index, Comorbidity, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.